---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-25-000088"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T02:59:25.769346+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Recursion Pharmaceuticals stockholders elect directors, approve exec comp, ratify auditor at 2025 meeting

## Summary
- Elected Zachary Bogue (242.3M for, 4.0M withheld), Zavain Dar (203.3M for, 42.9M withheld), Robert Hershberg (233.5M for, 12.8M withheld) as Class I directors.
- Advisory resolution to approve executive compensation approved with 239.9M for, 3.2M against, 3.1M abstain, 93.4M broker non-votes.
- Ratification of PwC as independent auditor for FY2025 approved with 334.6M for, 2.0M against, 3.1M abstain.

## SEC filing metadata
- accession: 0001601830-25-000088
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000088/0001601830-25-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000088/rxrx-20250618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-25-000088
- JSON: https://secwatch.observer/filing/0001601830-25-000088.json
- Plain text: https://secwatch.observer/filing/0001601830-25-000088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.